Skip to main content
Log in

Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The appearance of moderate jaundice with mildly raised levels of plasma bilirubin is an uncommon complication of thyrotoxicosis and is usually accompanied by signs of right heart failure. Some described cases were actually related, at least in part, to autoimmune chronic hepatitis. In this paper we describe a case of thyrotoxicosis accompanied by deep jaundice with very high levels of bilirubin occuring in the absence of cardiac failure and with no signs of hepatitis. Jaundice disappeared shortly after the start of thyrostatic drug treatment, supporting a possible detrimental effect of hyperthyroidism on the hepatic bilirubin metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Smanik E.J., Barkoukis H., Mullen K.D., McCullough A.J. The liver and its effect on endocrine function in health and disease. In: Schiff L., Schiff E.R. (Eds.), Diseases of the liver, ed. 7 J.B. Lippincott Company, Philadelphia, 1993, p. 1373.

    Google Scholar 

  2. Donner H.P., Parada J., Aliaga C., Hoyl C. The liver in thyrotoxicosis. Arch. Intern. Med. 120: 25, 1967.

    Article  Google Scholar 

  3. Fong T.L., McHutchison J.G., Reynolds T.B. Hyperthyroidism and hepatic disjunction. A case series analysis. J. Clin. Gastroenterol. 14: 240, 1992.

    Article  CAS  PubMed  Google Scholar 

  4. Raviolo P., Rizzetto M., Tabone M., De la Pierre M., Recchia S., Verme G. Colestasi intraepatica in corso di ipertiroidismo. Recenti Prog. Med. 82: 319, 1991.

    CAS  PubMed  Google Scholar 

  5. Ingbar I.H. Thyroid storm or crisis. In: Wermer S.C., Ingbar S.H. (Eds.), The thyroid: a fundamental and clinical text. Harper Row, New York, 1978, p. 800.

    Google Scholar 

  6. Yao J.D.C., Gross J.B., Ludwig J., Purnell D.C. Cholestatic jaundice in hyperthyroidism. Am. J. Med. 86: 619, 1989.

    Article  CAS  PubMed  Google Scholar 

  7. Greenberger N.J., Milligan F.D., DeGroot L.J., Isselbacher K.J. Jaundice and thyrotoxicosis in the absence of congestive heart failure. A study of four cases. Am. J. Med. 36: 840, 1964.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson P.J. The effet of endocrine diseases on liver function. In: McIntyre N., Benhamou- J.P., Bircher J., Rizzetto M., Rodes J. (Eds.), Oxford textbook of clinical hepatology. Oxford Medical Publications, Oxford, England, 1991, p. 1195.

    Google Scholar 

  9. Sola J., Pardo-Mindan F.J., Zozaya J., Quiroga J., Sangro B., Prieto J. Liver changes in patients with hyperthyroidism. Liver 11: 193, 1991.

    Article  CAS  PubMed  Google Scholar 

  10. Cooper D.S. Antithyroid drugs. N. Engl. J. Med. 311: 1353, 1984.

    Article  CAS  PubMed  Google Scholar 

  11. Cooper D.S., Kaplan M.M., Ridgway G., Maloof F., Daniels G.H. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann. Intern. Med. 90: 164, 1979.

    Article  CAS  PubMed  Google Scholar 

  12. Van Thiel D.H., Stone B.G., Schave R.R. The liver and its effect on endocrine function in health and disease. In: Schiff L., Schiff E.R. (Eds.), Diseases of the liver, ed. 6. J.B. Lippincott, Philadelphia, 1987, p. 129.

    Google Scholar 

  13. VanSteerbergen W., Fevery J., DeGroot J. Thyroid hormones and the hepatic handling of bilirubin II. Effects of hypothyroidism and hyperthyroidism on the apparent maximal biliary secretion of bilirubin in the Wistar rat. Hepatology 7: 229, 1988.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Babini, G., Gurioli, L., Rizzi, R. et al. Appearance of severe jaundice after radiometabolical treatment of thyrotoxicosis. J Endocrinol Invest 22, 209–211 (1999). https://doi.org/10.1007/BF03343543

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343543

Key-words

Navigation